Cytosorbents CORP (CTSO) — 10-K Filings
All 10-K filings from Cytosorbents CORP. Browse 3 Annual Report reports with AI-powered summaries and risk analysis.
10-K Filings (3)
-
Cytosorbents Pushes US Approval for Blood Thinner Reversal Device
— Mar 30, 2026 Risk: high
Cytosorbents Corp (CTSO) reported a focus on its proprietary blood purification technologies, particularly CytoSorb and the investigational DrugSorb-ATR. CytoSo -
Cytosorbents Corp Files 2024 Annual Report
— Mar 31, 2025 Risk: medium
Cytosorbents Corporation filed its 10-K for the fiscal year ending December 31, 2024. The company, formerly known as MedaSorb Technologies CORP and GILDER ENTER -
Cytosorbents Corp Files 2023 Annual Report on Form 10-K
— Mar 15, 2024 Risk: medium
Cytosorbents Corp (CTSO) filed a Annual Report (10-K) with the SEC on March 15, 2024. Cytosorbents Corp filed its 10-K report for the fiscal year ending Decembe
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX